Company intelligence / Profile preview
Chengdu FANXI Biopharma
Chengdu, Sichuan, China
- Ownership
- Private
- Development stage
- Other
01
Overview
Chengdu Fanxi Biopharma is a clinical-stage biotechnology company based in Chengdu, China, specializing in the development of innovative small molecule drugs. The company leverages advanced protein degradation technologies, including Proteolysis Targeting Chimeras (PROTACs) and molecular glues, to address previously "undruggable" targets. Its lead program, FX-9098, is an orally bioavailable AR-PROTAC designed for the treatment of metastatic castration-resistant prostate cancer. Fanxi Biopharma aims to provide transformative therapies for patients with cancer and autoimmune disorders through its proprietary discovery platforms. The company is supported by prominent venture capital firms and is located within the Chengdu Tianfu International Bio-town.
- Therapeutic areas
- OncologyImmunology
- Modalities
- Small moleculeProteolysis-targeting chimera therapyMolecular glue therapy
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Beyond the preview
Go deeper on Chengdu FANXI Biopharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Chengdu FANXI Biopharma.